NEW YORK (360Dx) – The vast majority of screening recommendations for rare diseases in newborns are made without a systematic review of available evidence, researchers in the UK reported on Wednesday.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.